Publisher
Springer Berlin Heidelberg
Reference33 articles.
1. Anderlini P, Körbling M, Dale D. Gratwohl A, Schmitz N, Stroncek D, Howe C, Leitman S, Horowitz M, Gluckman E, Rowley S, Przpiorka D, Champlin R (1997) Allogeneic blood stem cell transplantation: consideration for donors. Blood 90: 903–908
2. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB (1978) Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique. Blood 52: 323–331
3. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A (1996). Transfusion-related acute lung injury due to HLA-A2 antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 93: 707–13
4. Bux J, Cassens U, Dielschneider T, Duchscherer T, Eichler H, Haas C, Haustein B, Moog R, Peschke H, Reil A, Schlenke P, Ullrich H, Wiesneth M. (2002). Results of the German multicenter Study »Treatment of blood donors with recombinant G-SF for granulocyte apheresis. Vox Sang 83 (suppl. 2): 234–235
5. Cavallaro AM, Lilleby, K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI (2000) Three to six year follow-up of normal donors who received recombinant human granulocyte colonystimulating factor. Bone marrow Transplant 25: 85–89